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g biocatalyst -1 (1128 mg h -1 g biocatalyst -1 ) were obtained. The second step, N-acyl 3-amino-1,2-
26
propanediol O-acylation, was similarly optimized and in addition the effect of the substrate 27 molar ratio was studied. Thus, an optimal pseudo-ceramide synthesis yield of 54% and a 28 production rate of 0.46 mmol h -1 g biocatalyst -1 (261 mg h -1 g biocatalyst -1 ) were reached at a 1:3 ratio
Introduction

39
Ceramides are natural compounds derived from the N-acylation of sphingosine and are key 40 intermediates in the biosynthesis of all complex sphingolipids. Like their synthetic analogs,
41
they have been widely used in the cosmetic and pharmaceutical industries. Indeed, due to Reuil, France). 
Continuous process using a packed-bed bioreactor system for the Novozym
® 127
435-catalyzed synthesis of 1-O,3-N-diacyl 3-amino-1,2-propanediol-type
First step: N-acylation of 3-amino-1,2-propanediol
148
In the first step, the reaction mixture contained 3-amino-1,2-propanediol 1, a fatty acid
149
(stearic acid 2a, myristic acid 2b, lauric acid 2c, oleic acid 2d or linoleic acid 2e), which was 150 used as an acyl donor, and a tert-amyl alcohol/n-hexane (50:50 v/v) mixture used as the 151 reaction solvent. 
Second step: O-acylation of N-acyl 3-amino-1,2-propanediol
153
In the second step, the reaction mixture contained the N-stearyl 3-amino-1,2-propanediol 3a 154 produced during the first step, myristic acid 2b, which was used as an acyl donor and a tert-
155
amyl alcohol/n-hexane (50:50 v/v) mixture used as the reaction solvent. 
HPLC/MS analysis
To monitor the reaction, a 500 µl sample was taken from the product container when the 158 continuous process was complete, after 1 h of reaction. The study of the operational stability
159
of Novozym ® 435 in the continuous packed-bed bioreactor was carried out in a slightly 160 different manner: 500 µl samples were taken from the packed-bed output at different times 161 over a 3-week period. In each case, 500 µl of a methanol/chloroform (50:50 v/v) mixture were 162 added to each sample in order to homogenize the reaction medium at room temperature.
163
Structural and quantitative analyses of the reaction products were then conducted on these 164 samples using a LC/MS-ES system from Agilent (1100 LC/MSD Trap mass spectrometer 165 VL) with a C18 Prontosil 120-5-C18-AQ reversed-phase column (250×4 mm, 5 µm; Bischoff
166
Chromatography, Germany). The elution of the reaction samples was carried out at room 167 temperature and at a flow rate of 1 ml min -1 using a gradient that was derived from two eluent 168 mixtures ( Table 1) . The products were detected and quantified by differential refractometry
169
and UV detection at 210 nm. Quantification was performed against external calibration lines 170 prepared using the appropriate acylated products as standards. These standards were 171 synthesized using operating conditions in which only a specific standard could be formed 172 using a given acyl donor, then purified and structurally characterized. Low-resolution mass 173 spectral analyses were obtained by electrospray in the positive detection mode. Nitrogen was 174 used as the drying gas at 15 l min -1 , 350 °C and at a nebulizer pressure of 4 bars. The scan 175 range was 50-1000 m/z using five averages and 13,000 m/z per second resolution. The 176 capillary voltage was 4000 V. Processing was done offline using HP Chemstation software.
177 Table 1 178
Purification and characterization of reaction products
179
The reaction products were purified with a preparative HPLC system from Agilent (1200 temperature and at a flow rate of 5 ml min -1 . The purified products were then characterized by 1 
Results and discussion
233
The continuous enzymatic synthesis of 1-O,3-N-diacyl 3-amino-1,2-propanediol-type pseudo- propanediol (amide) synthesized in step 1. In order to promote both the synthesis and the 240 solubility of the products, all the reactions were carried out at 55°C.
241
A tert-amyl alcohol/n-hexane mixture (50:50 v/v) was chosen as the reaction solvent on the 
281
All these preliminary results showed that the selectivity of both steps of the process does not 282 need to be controlled during its implementation. Nevertheless, despite being encouraging in 283 terms of yield and production rate, they were not satisfying enough to envisage scaling up the 284 process. Starting from this fact, we thus concentrated our efforts on optimizing both steps of 285 the process. For that purpose, the influences of feed flow rate, quantity of biocatalyst,
286
substrate concentration and substrate molar ratio were examined. These parameters are likely
287
to have a significant effect on the yield and productivity of a continuous enzymatic process. 
Effect of feed flow rate
290
The feed flow rate plays an essential role in the continuous operation because it is related to 291 the residence time of the substrates and products in the column. In order to achieve a higher 292 synthesis yield for each step of the process, a sufficient residence time is needed to ensure that 293 the substrate is interacting with the enzyme's active site. We thus examined the effect of feed 294 flow rate on both synthesis yield and production rate (Fig. 2 ).
295
Fig. 2 296
During the first step, the flow rate was varied from 125 to 1000 µl min -1 ( Fig. 2A) . The amide 297 3a yield was relatively constant and close to 80% from 125 to 500 µl min -1 . In parallel, the 298 amide 3a production rate was shown to increase to a maximum value close to 6 mmol h was considered as the optimum flow rate for step 1.
306
During the second step, the flow rate was varied from 125 to 500 µl min -1 (Fig. 2B ). Again, a 307 relatively constant yield of pseudo-ceramide 4 of roughly 25% was obtained using flow rates 308 within this range, with a maximum yield of 30% at a flow rate of 250 µl min -1 . The reduction 309 in the substrate residence time in the packed-bed bioreactor caused by the increase in the flow 310 rate thus had no effect on the yield, as was already observed for the first step. In contrast, the 
Effect of the quantity of biocatalyst
317
The effect of the quantity of biocatalyst on both yield and production was investigated using 318 various quantities of Novozym ® 435 packed into the packed-bed continuous reactor (Fig. 3) . During the first step, the quantity of biocatalyst was varied from 215 to 1800 mg (Fig. 3A) .
321
The lowest biocatalyst quantity of 215 mg resulted in the lowest amide 3a yield obtained in 322 this study (17% despite the non-optimal production rate.
332
During the second step, the quantity of biocatalyst was varied from 430 to 2700 mg (Fig. 3B) .
333
There was a degree of similarity in terms of the change in both the yield and the production 334 rate of pseudo-ceramide 4 and amide 3a. The effect of substrate concentration on both synthesis yield and production rate was 359 investigated using various concentrations of acyl acceptor and acyl donor under 360 stoichiometric conditions (Fig. 4) . The results could not be interpreted when the substrate 361 concentration was higher than 100 mM due to the turbidity of the reaction mixture. This 362 resulted in a partial solubility of the amphiphilic amide 3a produced in step 1, or used as a 363 substrate in step 2 in the tert-amyl alcohol/n-hexane mixture (50:50 v/v) reaction solvent.
364
Indeed this partial substrate solubility caused plugging problems in the packed-bed bioreactor,
365
which precluded the development of a continuous process under these conditions.
366
Fig. 4 367
The use of substrate concentrations below 100 mM during the first step appeared to have very 368 little impact on the yield of amide 3a, which had an average value of 82% (±5% process by varying the substrate molar ratio in order to improve the yield in step 2. 
Effect of substrate molar ratio
The effect of substrate molar ratio on both the synthesis yield and the production rate of 399 pseudo-ceramide 4 (step 2) was investigated using various myristic acid 2b concentrations 400 and a fixed N-stearyl 3-amino-1,2-propanediol 3a concentration of 50 mM. 
Variation of the acyl donor nature
433
In this part, the nature of the acyl donor was varied and evaluated at step 1 of the process. N-
434
acylation of 3-amino-1,2-propanediol was thus performed to compare five acyl donors, three 435 saturated fatty acids of various chain length (C12-C18) and two unsaturated C18 fatty acids.
436
The conditions previously optimized in terms of feed flow rate, substrate concentration, 437 quantity of biocatalyst and bioreactor design were used in the process. Fig. 6 shows the yields
of N-stearyl-, N-myristyl-, N-lauryl-, N-oleyl-and N-linoleyl-3-amino-1,2-propanediol
439
(amides 3a, 3b, 3c, 3d and 3e, respectively) obtained after continuous Novozym ® -435-
440
catalyzed N-acylation of 3-amino-1,2-propanediol 1 using stearic acid 2a, myristic acid 2b, 441 lauric acid 2c, oleic acid 2d and linoleic acid 2e as acid donors, respectively. We observed that the yields obtained with saturated fatty acids 2a, 2b and 2c ranged from 444 87% with lauric acid 2c to 95% with myristic acid 2b, which indicated that acyl chain length had no significant effect on the amide yield. In addition, the use of unsaturated fatty acids 2d
446
(C18:1) and 2e (C18:2) gave yields of 85% and 80%, respectively. These results were barely 447 lower than the yield of 92% obtained using a saturated C18 fatty acid, stearic acid 2a. continuous N-acylation of 3-amino-1,2-propanediol 1 was carried out using lauric acid 2c as 460 the acyl donor (Fig. 7) . 435. This high stability may be partly related to the reaction solvent used. Indeed, water is 466 produced during a reverse hydrolysis reaction so controlling water activity will consequently 467 be of great importance, especially in a continuous process. According to the literature, a polar 468 solvent such as tert-amyl alcohol can be used to control water activity in a continuous acylation process [39, 40] . The tert-amyl alcohol polarity would thus enable the water 470 produced to be evacuated, resulting in a partial drying of the immobilized lipase. As a result,
471
optimal water activity would be maintained inside the reactor and optimum enzymatic activity 472 would remain stable for a long time.
473
The excellent stability of Novozym ® 435 in the continuous packed-bed bioreactor allowed us 474 to envisage further large scale pseudo-ceramide production given that the cost of the 475 biocatalyst would not be a limiting factor. 
Scale up of the bioreactor design
477
In order to perform a future scale-up of the packed-bed bioreactor to a pilot scale, the 478 influence of reactor design on the yield and production rate of pseudo-ceramide 4 (step 2) was varied from 100 to 1200 µl min -1 to change the residence time of the substrates (Fig. 8) . These results show that it is essential to use a long column with a small diameter such as 
Economic evaluation of the process
522
The final objective of this work was to perform an economic evaluation of our continuous 523 process under the optimal synthesis conditions for the two steps of the process. The economic 524 viability of an enzymatic synthesis process is determined by several key variables including 525 the manufacturing cost, the environmental cost, and the selling price and marketing cost for 526 the product. The term "manufacturing cost" is used to describe the total costs involved in the 527 manufacture of a synthetic product, which includes the cost of the biocatalyst, the chemicals, 528 the solvents, the equipment, the energy and other operational costs. In our case, we observed 529 the economic impact of three parameters which directly influence the manufacturing cost: the 530 cost of the biocatalyst, the substrates and the organic solvents (reaction solvents and solvents 531 used for the purification of the synthesis products).
532
In order to achieve a better assessment of the economic cost, we drew up a balance sheet of 533 the two steps of the process. Under our optimized experimental conditions used at a 4-fold 534 scale-up, an amide yield of 90% and a production rate of 1821 mg h -1 were obtained at step 1
535
(N-acylation) using 3300 mg of biocatalyst packed into the bioreactor. Assuming a biocatalyst substrates and organic solvents represent 1%, 18% and 71% of the product price, respectively.
548
The cost of the biocatalyst is usually one of the essential factors of the economic cost of an 549 enzymatic synthesis process due to the high price of biocatalysts (Novozym ® 435: 1100 €/kg).
550
However, it is noteworthy that the pseudo-ceramide productivity of our continuous process in 
Conclusion
562
In this work, we developed a new efficient continuous process for the selective Novozym 578
These results clearly demonstrate that this two-step process has great potential for the process, so its use for the synthesis of different pseudo-ceramides can be seriously envisaged.
586
Finally, in order to better assess the economic cost of pseudo-ceramide production we drew 587 up a balance sheet of the two steps of the process at a 4-fold scale-up. Step 1:
Step 2: 
